Cleared Special

K100108 - AMEDICA DRUG TEST THC

K100108 is the FDA 510(k) clearance for AMEDICA DRUG TEST THC by Amedica Biotech, Inc.. It is a Class 2 Chemistry device (product code NGL) cleared through the Special 510(k) pathway after a 90-day FDA review.

K100108 · Amedica Biotech, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2010
Decision
90d
Days
Class 2
Risk

K100108 is an FDA 510(k) clearance for the AMEDICA DRUG TEST THC, COC, OPI, AMP, MET, PCP, BAR, BZO, MDMA, OXY, TCA. Classified as Test, Opiates, Over The Counter (product code NGL), Class II - Special Controls.

Submitted by Amedica Biotech, Inc. (Hayward, US). The FDA issued a Cleared decision on April 14, 2010 after a review of 90 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.3650 - the FDA in vitro diagnostics and chemistry framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Amedica Biotech, Inc. devices

Submission Details

510(k) Number K100108 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 14, 2010
Decision Date April 14, 2010
Days to Decision 90 days
Submission Type Special
Review Panel Chemistry (CH)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
2d slower than avg
Panel avg: 88d · This submission: 90d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code NGL Test, Opiates, Over The Counter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.3650
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - NGL Test, Opiates, Over The Counter

All 21
Devices cleared under the same product code (NGL) and FDA review panel - the closest regulatory comparables to K100108.
BIOEASY Multi-Drug Test Cup
K193480 · Shenzhen Bioeasy Biotechnology Co., Ltd. · Jan 2020
CLUNGENE Multi-Drug Test Dip Card, CLUNGENE Multi-Drug Test Easy Cup
K190412 · Hangzhou Clongene Biotech Co., Ltd. · Mar 2019
CLUNGENE Multi-Drug Test Dip Card, CLUNGENE Multi-Drug Test Easy Cup
K181790 · Hangzhou Clongene Biotech Co., Ltd. · Jul 2018